| Computation of Basic and Diluted Net Loss Per Common Share |
The following table presents the computation of basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(22,231 |
) |
|
$ |
(23,296 |
) |
|
$ |
(47,429 |
) |
|
$ |
(46,259 |
) |
Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
37,814,019 |
|
|
|
36,848,602 |
|
|
|
37,583,623 |
|
|
|
36,718,994 |
|
Less: Weighted-average shares subject to repurchase |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Denominator for basic and diluted net loss per share attributable to common stockholders |
|
|
37,814,019 |
|
|
|
36,848,602 |
|
|
|
37,583,623 |
|
|
|
36,718,994 |
|
Basic and diluted net loss per share |
|
$ |
(0.59 |
) |
|
$ |
(0.63 |
) |
|
$ |
(1.26 |
) |
|
$ |
(1.26 |
) |
|
| Effect of Anti-dilutive Securities |
The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Common stock options, restricted stock units and performance stock units |
|
|
10,711,822 |
|
|
|
10,949,114 |
|
|
|
10,781,071 |
|
|
|
10,850,896 |
|
Warrants to purchase common stock |
|
|
2,669,479 |
|
|
|
496,612 |
|
|
|
2,904,290 |
|
|
|
496,612 |
|
Common stock issuable in connection with convertible senior notes |
|
|
2,482,621 |
|
|
|
3,842,961 |
|
|
|
2,482,621 |
|
|
|
3,842,961 |
|
|
|
|
15,863,922 |
|
|
|
15,288,687 |
|
|
|
16,167,982 |
|
|
|
15,190,469 |
|
|